Your Partner in Delivering Successful Psychiatry Trials
Global experience with mental health research
The importance of mental health has increased within the medical community and the public at large, but the need for psychiatric treatments remains high.
Mental health conditions and substance use disorders affect roughly 13% of the global population and are attributed to 14.3% of deaths worldwide. There is an urgent need among patients and their loved ones for effective, novel treatment options for mental health conditions.
There are a number of challenges you may face in mental health clinical projects—but as your CRO partner, PPD enables you to manage the specific challenges that may arise, such as subjective assessments, inter-rater reliability, scale validation and placebo response rates. Our psychiatric experts have experience designing and executing trials for various mental health disorders related to:
- behavior
- cognition
- maladaptation
- mood
- perceptions
The medical experts at our Rare Disease and Pediatric Center of Excellence (COE) focus on treating rare and pediatric conditions, including childhood psychiatric disorders such as autism and Rett syndrome.
Want to learn more?
Psychiatry studies
Sites
Patients
Confidently advance your psychiatry clinical trial program
Minimizing the risks inherent in psychiatry studies—such as placebo response rates—without having to compromise on identifying, recruiting and properly evaluating the appropriate patients is vital to your study. To proactively overcome issues that may negatively impact signal detection, we apply our cross-functional expertise in risk mitigation including:
- Expectation biases
- Inconsistencies in disease severity assessment
- Misconceptions of treatment versus research
- Natural histories of the disease
- Subjective endpoints